Therapy Areas: Inflammatory Diseases
25 November 2020 - - Enrolment of 327 patients with mild-to-moderate symptoms of SARS-CoV-2 infection has completed in the global Phase II clinical trial of CT-P59, an anti-COVID-19 monoclonal antibod...
25 November 2020 - - US-based clinical-stage company Vedanta Biosciences has appointed Troy Ignelzi as an independent member of its board of directors, the company said.

Ignelzi has more ...
23 November 2020 - - Baricitinib, a drug it first identified as a potential treatment for COVID-19 by the company has been granted Emergency Use Authorization by the US Food and Drug Administration, U...
20 November 2020 - - US-based biotherapeutics company PureTech Health plc (LSE: PRTC) (NASDAQ: PRTC) has completed a Phase 1 multiple ascending dose and food effect study for LYT-100 (deupirfenidone),...
19 November 2020 - Digital health company, NeurodigitX reported on Wednesday the launch of Plastic Health platform, which allows a powerful mainstream bloodless assessment of inflammation levels in th...
18 November 2020 - - US-based Omeros Corp. (NASDAQ: OMER) has completed the rolling submission of its Biologics License Application to the US Food and Drug Administration for narsoplimab for the treat...
Related Headlines